The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $274.82

Today's change-0.59 -0.21%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $274.82

Today's change-0.59 -0.21%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.

Biogen Inc down (U.S.)$0.59

Biogen Inc closed lower Friday, dropping (U.S.)$0.59 or 0.21% to (U.S.)$274.82. Over the last five days, shares have lost 0.46% and are down 3.09% for the last year to date. This security has underperformed the S&P 500 by 7.23% during the last year.

Key company metrics

  • Open(U.S.) $277.08
  • Previous close(U.S.) $275.41
  • High(U.S.) $278.10
  • Low(U.S.) $272.87
  • Bid / Ask(U.S.) $270.00 / (U.S.) $276.80
  • YTD % change-3.09%
  • Volume1,368,217
  • Average volume (10-day)1,963,256
  • Average volume (1-month)1,695,339
  • Average volume (3-month)1,774,813
  • 52-week range(U.S.) $223.02 to (U.S.) $333.65
  • Beta0.79
  • Trailing P/E16.25×
  • P/E 1 year forward13.13×
  • Forward PEG1.92×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $16.91
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,8722,9562,8942,727
Total other revenue--------
Total revenue2,8722,9562,8942,727
Gross profit2,4942,5392,5242,414
Total cost of revenue379417370313
Total operating expense1,9861,5311,4341,348
Selling / general / administrative496463492497
Research & development534529473437
Depreciation / amortization1041009389
Interest expense (income), net operating--------
Unusual expense (income)463181112
Other operating expenses, total115-6--
Operating income8861,4251,4611,378
Interest income (expense), net non-operating-65-66-66-63
Gain (loss) on sale of assets--------
Other--------
Income before tax8381,3671,4021,326
Income after tax6481,0301,048969
Income tax, total190337354356
Net income6491,0331,050971
Total adjustments to net income--------
Net income before extra. items6491,0331,050971
Minority interest1312
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6491,0331,050971
Inc. avail. to common incl. extra. items6491,0331,050971
Diluted net income6491,0331,050971
Dilution adjustment--------
Diluted weighted average shares217219219219
Diluted EPS excluding extraordinary itemsvalue per share2.994.714.784.43
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.644.774.824.47